سعر بنتازا 1 جرام 28 اقماع /لبوس 2026

Mesalazine 1 g suppositories (28) by Ferring, marketed in Egypt by Multipharma, for distal ulcerative colitis/proctitis.

• Mildly to moderately active ulcerative proctitisPopulation: AdultsDailyMed (U.S. National Library of Medicine)

• Most common (>=1%): dizziness, rectal pain, fever, rash, acne and colitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known or suspected hypersensitivity to salicylates, aminosalicylates or any suppository ingredient.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Renal impairment, acute intolerance syndrome, hypersensitivity (myocarditis/pericarditis), hepatic failure, severe cutaneous reactions, photosensitivity and nephrolithiasis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Nephrotoxic agents including NSAIDsIncreased risk of nephrotoxicity; monitor renal function.DailyMed (U.S. National Library of Medicine)
• Azathioprine or 6-mercaptopurineIncreased risk of blood disorders; monitor complete blood and platelet counts.DailyMed (U.S. National Library of Medicine)

• Limited published data are insufficient to inform a drug-associated risk; no teratogenicity in rats or rabbits.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Mesalamine and its N-acetyl metabolite are present in milk in small amounts; monitor breastfed infants for diarrhoea.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Mesalazine: Not fully understood; appears to act topically on colonic epithelium, possibly diminishing inflammation by blocking cyclooxygenase and inhibiting prostaglandin production.